Built from Waystar Holding Corp.’s own filings with the U.S. Securities and Exchange Commission (SEC). Figures are as reported, with per-share history restated onto today’s share basis. This describes a business — it is not investment advice and not a recommendation to buy or sell anything.
The themes Waystar is part of, the highest-graded companies in its industry, and the companies in its sector whose grade rose recently.
Graded A or B and worth $2B or more: A first, then the largest.
Rose to A or B on a filing in the last 90 days, worth $2B or more: largest first.
WAY · Nasdaq · Healthcare · Health Information Services
$28.82-1.6%Nov 11 close
Figures through September 30, 2026, from the 10-Q filed November 2, 2026
Company outlook: revenue of $1.3B to $1.3B for Fiscal year 2026 — up 16.6% on a year earlier
Just reported
From Waystar's results release of November 2, 2026; its quarterly report has since been filed.
Actual
$325.6M
+21% y/y
+1.9% q/q
Guided
—
No guide given
Actual
$0.16
-5.9% y/y
-24% q/q
Guided
—
No guide given
Actual
$61.3M
+1.7% y/y
-19% q/q
Guided
—
No guide given
Full year 2026
Set against the company's own guidance and the same quarter a year earlier, not analysts' estimates, which we do not hold. Adjusted figures are the company's own non-GAAP measures, as stated in the release.
Grade B+
The band under the price shows the grade on each date, built only from filings that were public by then.
Showing 2 of 8 quarters of Waystar Holding Corp.’s grade history. The other 6 go back to February 2025.